国家药监局召开全国“十五五”药品规划编制工作座谈会

Core Insights - The meeting on August 28 emphasized the need for a comprehensive approach to drug regulation during the "14th Five-Year Plan" period, focusing on safety and innovation [1] Regulatory Framework - The meeting highlighted the importance of establishing a robust drug safety responsibility system and a full-chain regulatory mechanism to ensure high-level drug safety [1] - It called for the enhancement of law enforcement and case handling mechanisms to improve regulatory effectiveness [1] Reform and Innovation - There is a strong push for deepening reforms in drug review and approval systems, promoting the inheritance and innovation of traditional Chinese medicine, and accelerating the development of high-end medical devices [1] - The meeting also addressed the need to reform the review and approval mechanisms for cosmetics to foster high-quality development [1] Standards and Talent Development - The need to improve the regulatory standards system and strengthen technical support capabilities was emphasized, alongside a commitment to information technology leadership [1] - The meeting stressed the importance of building a high-quality drug regulatory talent team to enhance overall regulatory capabilities [1]